Free Trial

Veeva Systems Inc. (NYSE:VEEV) Given Consensus Recommendation of "Moderate Buy" by Analysts

Veeva Systems logo with Medical background

Key Points

  • Veeva Systems Inc. (NYSE:VEEV) has received a consensus recommendation of "Moderate Buy" from 25 research firms, with a target price averaging $307.58.
  • The company reported $1.26 EPS for the last quarter, missing estimates by ($0.64), but achieved revenue of $789.08 million, exceeding expectations.
  • Recent insider sales included Eleni Nitsa Zuppas selling 6,000 shares at a price of $306.62, representing a 19.15% decrease in her stake in Veeva Systems.
  • Five stocks to consider instead of Veeva Systems.

Shares of Veeva Systems Inc. (NYSE:VEEV - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twenty-five research firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and sixteen have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $307.5833.

Several equities analysts have weighed in on VEEV shares. Barclays lifted their price target on shares of Veeva Systems from $300.00 to $325.00 and gave the company an "overweight" rating in a report on Thursday, August 28th. Stifel Nicolaus lifted their price target on shares of Veeva Systems from $295.00 to $320.00 and gave the company a "buy" rating in a report on Thursday, August 28th. Oppenheimer reaffirmed an "outperform" rating and set a $325.00 price target on shares of Veeva Systems in a report on Thursday, August 28th. Needham & Company LLC lifted their price target on shares of Veeva Systems from $300.00 to $355.00 and gave the company a "buy" rating in a report on Thursday, August 28th. Finally, Truist Financial lifted their price target on shares of Veeva Systems from $268.00 to $275.00 and gave the company a "hold" rating in a report on Thursday, August 28th.

Check Out Our Latest Analysis on Veeva Systems

Veeva Systems Trading Up 0.6%

Shares of NYSE VEEV opened at $287.81 on Wednesday. The firm has a 50 day moving average of $283.06 and a 200 day moving average of $265.77. The firm has a market capitalization of $47.17 billion, a price-to-earnings ratio of 59.10, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. Veeva Systems has a 12-month low of $201.54 and a 12-month high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.90 by ($0.64). The business had revenue of $789.08 million for the quarter, compared to the consensus estimate of $768.49 million. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The business's quarterly revenue was up 16.7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.62 earnings per share. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Sell-side analysts predict that Veeva Systems will post 4.35 EPS for the current year.

Insider Buying and Selling at Veeva Systems

In other news, insider Eleni Nitsa Zuppas sold 6,000 shares of the business's stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the transaction, the insider owned 25,325 shares of the company's stock, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Jonathan Faddis sold 14,595 shares of the business's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $300.00, for a total transaction of $4,378,500.00. Following the completion of the transaction, the senior vice president directly owned 8,588 shares in the company, valued at $2,576,400. This trade represents a 62.96% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 24,665 shares of company stock valued at $7,438,000 over the last 90 days. 10.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Veeva Systems

Several hedge funds have recently modified their holdings of VEEV. Abound Financial LLC purchased a new stake in Veeva Systems during the first quarter valued at $25,000. ORG Partners LLC purchased a new stake in Veeva Systems during the first quarter valued at $26,000. Trust Co. of Toledo NA OH purchased a new stake in Veeva Systems during the second quarter valued at $29,000. Golden State Wealth Management LLC raised its stake in Veeva Systems by 152.9% during the first quarter. Golden State Wealth Management LLC now owns 129 shares of the technology company's stock valued at $30,000 after purchasing an additional 78 shares in the last quarter. Finally, Wayfinding Financial LLC purchased a new stake in Veeva Systems during the first quarter valued at $32,000. Hedge funds and other institutional investors own 88.20% of the company's stock.

About Veeva Systems

(Get Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Read More

Analyst Recommendations for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.